Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Natera To Contact Him Directly To Discuss Their Options
NEW YORK, NY - 
(NewMediaWire) - April 20, 2022 - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Natera, Inc. (“Natera” or the “Company”) (NASDAQ: NTRA).
There is no cost or obligation to you.
Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. A New York Times article published on January 1, 2022, questions the accuracy of noninvasive prenatal tests including those offered by Natera. According to the article, the Company's tests are incorrect up to 85% of the time. False positives result in follow-up testing which "can cost thousands of dollars, come with a small risk of miscarriage and can't be performed until later in pregnancy."
On March 9, 2022, Hindenburg Research published a report on Natera claiming that: "Natera's revenue growth has been fueled by deceptive sales and billing practices aimed at doctors, insurance companies and expectant mothers."
Based on this news, shares of Natera fell by 30% in intraday trading.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
View the original release on www.newmediawire.com
